Matthew Shaun Bowden

age:

47 years

appointments:

27 active

1 prior

primary industry:

Other professional, scientific and technical activities

about Matthew

Since 2019, Mr Bowden has been a director of 28 companies, the current directorship have a combined turnover of approximately £3b.

Combined Valuation

£155.7b

Combined Turnover

£3b

active directorships over time

company
turnover
valuation
start
end
status
role
astrazeneca intermediate holdings limited-£100.2bMay 2025-OpenDirector
astrazeneca treasury limited-£18.9bApr 2025-OpenDirector
kudos pharmaceuticals limited£670m£11.5bFeb 2019-OpenDirector
medimmune limited£2.2b£11bFeb 2019-OpenDirector
cambridge antibody technology group limited-£7.1bFeb 2019-OpenDirector
azenco4 limited-£2.6bFeb 2019-OpenDirector
astrazeneca us investments limited-£1.3bFeb 2019-OpenDirector
astra pharmaceuticals limited-£1.2bFeb 2019-OpenDirector
zenco (no. 8) limited-£1.2bFeb 2019-OpenDirector
astrazeneca investments limited-£297.1mFeb 2019-OpenDirector
medimmune u.k. limited£78.5m£130.4mFeb 2019-OpenDirector
astrazeneca japan limited-£60.1mFeb 2019-OpenDirector
astrapharm-£14.2mFeb 2019-OpenDirector
zeneca finance (netherlands) company-£1.1mFeb 2019-OpenDirector
kudos horsham limited-£1mFeb 2019-OpenDirector
astrazeneca finance limited-£220.8kFeb 2019-OpenDirector
azenco2 limited-£236.7Feb 2019-OpenDirector
astrazeneca quest limited-£236.7Feb 2019-OpenDirector
astrazeneca employee share trust limited-£236.7Feb 2019-OpenDirector
astrazeneca share trust limited-£236.7Feb 2019-OpenDirector
astrazeneca china uk limited-£113.4Feb 2019-OpenDirector
arrow therapeutics limited-£89.9Feb 2019-OpenDirector
azenco6 limited-£2.4May 2024-OpenDirector
azenco5 limited-£2.4May 2024-OpenDirector
astrazeneca nominees limited-£2.3Feb 2019-OpenDirector